{"id":3137,"date":"2023-07-13T20:58:13","date_gmt":"2023-07-13T18:58:13","guid":{"rendered":"https:\/\/delinaprej.eu\/?p=3137"},"modified":"2023-07-13T20:59:14","modified_gmt":"2023-07-13T18:59:14","slug":"okvirna-pogodba-podpisana-v-okviru-programa-eu-za-zdravje-da-se-zagotovi-hiter-odziv-na-prihodnje-zdravstvene-krize","status":"publish","type":"post","link":"https:\/\/delinaprej.eu\/index.php\/2023\/07\/13\/okvirna-pogodba-podpisana-v-okviru-programa-eu-za-zdravje-da-se-zagotovi-hiter-odziv-na-prihodnje-zdravstvene-krize\/","title":{"rendered":"Okvirna pogodba, podpisana v okviru programa EU za zdravje, da se zagotovi hiter odziv na prihodnje zdravstvene krize \ud83c\uddf8\ud83c\uddee"},"content":{"rendered":"<h6><strong>Namesto podnaslova: kako lepo je, ko zapravlja\u0161 tuj denar (dav\u010dnih obveznikov) in ti ni treba nikomur od njih (dav\u010dnih obveznikov) odgovarjati in skoraj nih\u010de izmed njih (dav\u010dnih obveznikov) niti ne ve, kdo ti sploh si in kdo te je tja namestil, povrh vsega ti dajo \u0161e \u00bbmastno\u00ab pla\u010do (seveda, iz denarja dav\u010dnih obveznikov).<\/strong><\/h6>\n<p><em><strong>Ali vas je kdo vpra\u0161al kako bodo uporabili VA\u0160 davkopla\u010devalski denar (325 milijonov odmerkov na leto!!!)?<\/strong><\/em><\/p>\n<p><em>30. junij 2023, Evropska izvajalska agencija za zdravje in digitalno tehnologijo<\/em><br \/>\n<span class=\"post_img_contaier\" data-image=\"\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3138\" src=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/07\/230630_EU-FAB-results_visual-300x169.jpeg\" alt=\"\" width=\"600\" height=\"338\" srcset=\"https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/07\/230630_EU-FAB-results_visual-300x169.jpeg 300w, https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/07\/230630_EU-FAB-results_visual-768x432.jpeg 768w, https:\/\/delinaprej.eu\/wp-content\/uploads\/2023\/07\/230630_EU-FAB-results_visual.jpeg 991w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/span><\/p>\n<p>Pandemija COVID-19 je pokazala, da mora biti Evropa bolje pripravljena na prihodnje izredne zdravstvene razmere.\u00a0Program\u00a0<strong>EU za<\/strong>\u00a0zdravje dobro odra\u017ea to potrebo: za\u0161\u010dita dr\u017eavljanov pred \u010dezmejnimi nevarnostmi za zdravje je med prednostnimi nalogami financiranja.<\/p>\n<p><strong>Evropska izvajalska agencija za zdravje in digitalno tehnologijo (HaDEA)<\/strong>\u00a0je<strong>\u00a0v imenu organa za pripravljenost in odzivanje na izredne\u00a0<\/strong>zdravstvene razmere (HERA) podpisala okvirno pogodbo s \u0161tirimi izvajalci, ki vzpostavljajo mre\u017eo\u00a0<strong>EU FAB\u00a0<\/strong>za zadostne in prilagodljive proizvodne zmogljivosti za razli\u010dne vrste cepiv (na osnovi mRNA, vektorjev in beljakovin).\u00a0Te zmogljivosti bodo \u0161e naprej delovale in se bodo lahko hitro aktivirale, kar bo zagotovilo skupno 325 milijonov odmerkov na leto v primeru izrednih razmer v javnem zdravju.<\/p>\n<p>Mre\u017ea EU FAB vklju\u010duje proizvajalce cepiv v EU (Belgija, Irska, Nizozemska, \u0160panija).\u00a0Ukrepi mre\u017ee bodo zapolnili vrzel med proizvodnjo in pove\u010danjem proizvodnje cepiv, hkrati pa zagotovili zmogljivost industrije za proizvodnjo zdravil, ki re\u0161ujejo \u017eivljenja.<\/p>\n<p><strong>Kako deluje EU FAB<\/strong><\/p>\n<p>EU FAB bo\u00a0<strong>EU pridr\u017eala proizvodne zmogljivosti za proizvodnjo cepiv<\/strong>\u00a0v primeru izrednih razmer v javnem zdravju. EU FAB bo deloval na naslednji na\u010din:<\/p>\n<ul>\n<li><strong>Faza pripravljenosti:\u00a0<\/strong>EU FAB si pridr\u017euje potrebno proizvodno zmogljivost. Objekti EU FAB zagotavljajo njihovo stalno pripravljenost za odzivanje na krizo, tako da posodabljajo svoje zmogljivosti, zagotavljajo usposabljanje osebja in spremljajo njihove dobavne verige, po potrebi vklju\u010dno s kopi\u010denjem zalog.<\/li>\n<li><strong>Krizna faza<\/strong>: Po priznanju izrednih razmer v\u00a0<strong>javnem zdravju se<\/strong>\u00a0Komisija odlo\u010di za nakup cepiv in aktiviranje EU FAB. Objekti EU FAB bodo nato hitro za\u010deli proizvajati in dobavljali cepiva v skladu z roki, dolo\u010denimi v nakupnih pogodbah.<\/li>\n<\/ul>\n<p><strong>Proizvajalci cepiv<\/strong><\/p>\n<p>EU FAB bo zajemala proizvodne zmogljivosti za mRNA, vektorska cepiva in cepiva na osnovi beljakovin. Izbrani proizvajalci cepiv so:<\/p>\n<ul>\n<li><strong>Cepiva na osnovi vektorjev:<\/strong>\u00a0Bilthoven Biologicals B.V.<\/li>\n<li><strong>Cepiva na osnovi beljakovin:<\/strong>\u00a0LABORATORIOS HIPRA S.A; CZ cepiva in Laboratorio Reig Jofre SA<\/li>\n<li><strong>cepiva proti mRNA:<\/strong>\u00a0Pfizer Ireland Pharmaceuticals in Pfizer Manufacturing Belgija<\/li>\n<\/ul>\n<p><a href=\"https:\/\/hadea.ec.europa.eu\/programmes\/eu4health\/230630-eu-fab-factsheet_en\" rel=\"noopener noreferrer nofollow\"><strong>Pregled mre\u017ee EU FAB je na voljo v informativnem pregledu.<\/strong><\/a><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_sl?etrans=sl#modal\" rel=\"noopener noreferrer nofollow\"><strong><em>EN<\/em>\u2022\u2022\u2022<\/strong><\/a><\/p>\n<h3>Ozadje<\/h3>\n<p><a href=\"https:\/\/ec.europa.eu\/health\/health-emergency-preparedness-and-response-hera_en\" rel=\"noopener noreferrer nofollow\">HERA<\/a><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_sl?etrans=sl#modal\" rel=\"noopener noreferrer nofollow\"><em>EN<\/em><strong>\u2022\u2022\u2022<\/strong><\/a>\u00a0je klju\u010dni steber\u00a0<a href=\"https:\/\/ec.europa.eu\/info\/strategy\/priorities-2019-2024\/promoting-our-european-way-life\/european-health-union_en\" rel=\"noopener noreferrer nofollow\">evropske zdravstvene unije<\/a><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_sl?etrans=sl#modal\" rel=\"noopener noreferrer nofollow\"><em>EN<\/em><strong>\u2022\u2022\u2022<\/strong><\/a>\u00a0in temeljno sredstvo za krepitev odzivanja EU na izredne zdravstvene razmere in pripravljenosti nanje. Vzpostavljen je bil za izbolj\u0161anje sposobnosti Evrope, da se hitro odzove na tak\u0161ne krize in da se evropskim dr\u017eavljanom omogo\u010di dostop do cepiv. Organ HERA se je v\u00a0<a href=\"https:\/\/health.ec.europa.eu\/publications\/hera-2023-work-plan_en\" rel=\"noopener noreferrer nofollow\">delovnem na\u010drtu<\/a>EN\u2022\u2022\u2022 za leto 2023 zavezal k nadaljnji pripravljenosti na pandemije in druge obse\u017ene zdravstvene krize s poudarkom na razpolo\u017eljivosti in dostopnosti zdravstvenih protiukrepov s petimi vodilnimi pobudami, od katerih je ena ustanovitev EU FAB.<\/p>\n<p>Mre\u017ea EU FAB je rezultat javnega razpisa\u00a0<a href=\"https:\/\/hadea.ec.europa.eu\/news\/eu4health-call-guarantee-fast-response-future-health-emergencies-2022-04-27_en\" rel=\"noopener noreferrer nofollow\">EU za zdravje, ki<\/a><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_sl?etrans=sl#modal\" rel=\"noopener noreferrer nofollow\"><em>EN<\/em><strong>\u2022\u2022\u2022<\/strong><\/a>\u00a0je bil v imenu organa HERA objavljen aprila 2022.\u00a0V razpisu bi lahko sodelovala farmacevtska podjetja in pogodbene proizvodne organizacije, ki zagotavljajo proizvodne storitve drugim podjetjem v farmacevtski industriji.<\/p>\n<p>Program EU za zdravje s prora\u010dunom v vi\u0161ini 5,3 milijarde evrov je \u010detrti in najve\u010dji med zdravstvenimi programi EU. Program EU za zdravje presega ambiciozen odziv na krizo zaradi COVID-19, da bi obravnaval odpornost evropskih zdravstvenih sistemov. Program zagotavlja financiranje nacionalnim organom, zdravstvenim organizacijam in drugim organom z nepovratnimi sredstvi in javnimi naro\u010dili, kar prispeva k bolj zdravi Evropi.<\/p>\n<p>HaDEA upravlja veliko ve\u010dino celotnega prora\u010duna EU za zdravje in izvaja program z upravljanjem razpisov za zbiranje predlogov in javnih razpisov v obdobju 2021\u20132027.<\/p>\n<p><a href=\"https:\/\/www.youtube.com\/playlist?list=PLLsnzVdgwImPXgFPYBYA0BbxbVZznDpI7\" rel=\"noopener noreferrer nofollow\"><strong>Oglejte si videoposnetke EU4Health o prednostnih nalogah financiranja.<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/ec.europa.eu\/commission\/presscorner\/detail\/en\/fs_22_7124\" rel=\"noopener noreferrer nofollow\">Preverite informativni pregled poro\u010dila o stanju pripravljenosti na zdravje in delovnega na\u010drta organa HERA<\/a><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_sl?etrans=sl#modal\" rel=\"noopener noreferrer nofollow\"><em>EN<\/em><strong>\u2022\u2022\u2022<\/strong><\/a>.<\/p>\n<p><em>Vir:\u00a0<\/em><a href=\"https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_en\" rel=\"noopener noreferrer nofollow\" data-link-auto=\"\"><em>https:\/\/hadea.ec.europa.eu\/news\/framework-contract-signed-under-eu4health-guarantee-fast-response-future-health-crises-2023-06-30_en<\/em><\/a><\/p>\n<p><em>Objavljeno na <a href=\"https:\/\/publishwall.si\/kvazdj\/qpost\/304150\" target=\"_blank\" rel=\"noopener\">https:\/\/publishwall.si\/kvazdj\/qpost\/304150<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Namesto podnaslova: kako lepo je, ko zapravlja\u0161 tuj denar (dav\u010dnih obveznikov) in ti ni treba nikomur od njih (dav\u010dnih obveznikov) odgovarjati in skoraj nih\u010de izmed njih (dav\u010dnih obveznikov) niti ne ve, kdo ti sploh si [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3138,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[41,5,7],"tags":[],"class_list":["post-3137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cepiva-vakcine","category-medicina","category-politika"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/3137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/comments?post=3137"}],"version-history":[{"count":6,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/3137\/revisions"}],"predecessor-version":[{"id":3144,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/posts\/3137\/revisions\/3144"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/media\/3138"}],"wp:attachment":[{"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/media?parent=3137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/categories?post=3137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/delinaprej.eu\/index.php\/wp-json\/wp\/v2\/tags?post=3137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}